Bolt Biotherapeutics, Inc. (BOLT) Form 8-K — Oct 6, 2026
Bolt Biotherapeutics entered into a Second Lease Amendment on October 1, 2026 with landlord HCP LS Redwood City LLC covering its 800 and 900 Chesapeake Drive corporate office, lab, and vivarium facilities in Redwood City, California. Under the amendment, Bolt paid the landlord $1.0 million and agreed the landlord can draw its existing $1.5 million letter of credit in full. The lease now expires early on December 31, 2027, or sooner if Bolt completes a financing or other strategic transaction.
Key figures
- Payment to landlord
- $1.0 million
- Accelerated lease expiration
- December 31, 2027
- Letter of credit surrendered
- $1.5 million
- Termination payment on corporate transaction
- $4.5 million
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.